miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesis

Affiliations

• ¹ Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
• ² EMBL Australia, Australian Regenerative Medicine Institute, Monash University, Clayton, VIC, Australia.
• ³ Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. sara.meyer@jefferson.edu.
• ⁴ Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. sara.meyer@jefferson.edu.